CompletedNot Applicable

Effect of mCIMT Casting on Speech-language Outcomes in Children With Hemiparesis

United States3 participantsStarted 2020-01-06

Plain-language summary

Modified constraint-induced movement therapy (mCIMT) has been successfully used with children who have hemiplegia (weakness or paralysis on one side of the body.) mCIMT uses a removable cast during treatment and home exercise programs. It has been found that mCIMT can improve use, strength and coordination of a child's affected hand, and may also help improve speech and language skills. The goal of this project is to investigate whether combining mCIMT with speech therapy will enhance speech outcomes in children with cerebral palsy.

Who can participate

Age range15 Months – 7 Years

SexALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion Criteria: * Previous diagnosis of Cerebral Palsy * Hemiplegia * Speech-Language Impairment * English as primary language spoken in the patient's home * Normal or corrected hearing and vision Exclusion Criteria: * Presence of co-morbid developmental disability (not including specific language impairment) which has an impact on cognition, sensory processing, and/or social-pragmatic function * Non-corrected hearing loss as evidenced by audiology report, failure to pass a newborn hearing screening, and/or performance on pure-tone testing. * Non-corrected vision impairments * Weakness on both sides or neither side of the body * Bilingual speakers or patients who speak languages other than English * Previous history of CIMT or mCIMT within the past 6 months.

What they're measuring

Probes

Timeframe: Up to 15 weeks

Trial details

NCT IDNCT04259814

SponsorShirley Ryan AbilityLab

Sponsor typeOTHER

Study typeINTERVENTIONAL

Primary completion2020-05-26

View on ClinicalTrials.gov More Speech and Language Disorder trials